Phase I/II Study With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Patient With Malignant Solid Tumors
Summary
The purpose of this phase I/II trial is to evaluate the safety and efficacy of GEN1042 in patients with locally advanced, or metastatic solid tumors, including pancreatic cancer.
General Information
NCT#: NCT04083599
Study ID: GCT1042-01
Trial Phase: Phase I/II
Trial Sponsor: Genmab
Therapies Used in This Trial: GEN1042